title: Short course chemotherapy for pulmonary tuberculosis.
abstract: A retrospective survey of the treatment of culture positive pulmonary tuberculosis with a standard 6-month course of unsupervised therapy, comprising rifampicin and isoniazid daily for 6 months with pyrazinamide for the first 8 weeks is reported. Of the 164 patients who commenced this regimen, 110 completed therapy as planned. There were five relapses, three of whom admitted significant non-compliance, giving a relapse rate of 4.59% (95% confidence interval, 1.49-10.7). The regimen gives satisfactory results in routine unsupervised treatment.
authors.affiliation: Newham Chest Clinic, London, U.K.
authors.forename: L P
authors.initials: LP
authors.lastname: Ormerod
authors.forename: O R
authors.initials: OR
authors.lastname: McCarthy
authors.forename: R M
authors.initials: RM
authors.lastname: Rudd
authors.forename: N
authors.initials: N
authors.lastname: Horsfield
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011718:Pyrazinamide / Q000008:administration & dosage* / Q000627:therapeutic use; D012293:Rifampin / Q000008:administration & dosage* / Q000627:therapeutic use; D012646:Self Administration; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin